K74.1 Hepatic sclerosis

Name of the Condition

• Hepatic Sclerosis (ICD-10-CM Code: K74.1)

Summary

Hepatic sclerosis is a condition characterized by the hardening of liver tissue due to scarring, which can impair liver function. This code specifically denotes sclerosis of the liver without cirrhosis, distinguishing it from more advanced liver disease. The scarring results from chronic injury or inflammation, though the underlying cause may not be specified.

Causes

Hepatic sclerosis typically develops as a response to ongoing liver damage. Common triggers include chronic viral hepatitis (e.g., hepatitis B or C), long-term alcohol use, non-alcoholic fatty liver disease (NAFLD), and autoimmune liver conditions. Prolonged exposure to toxins or certain medications may also contribute to the development of sclerosis.

Risk Factors

• Chronic viral hepatitis infections
• Excessive alcohol consumption
• Obesity and metabolic syndrome
• Type 2 diabetes
• High cholesterol or triglycerides
• Genetic predispositions to liver disease

Symptoms

Early stages of hepatic sclerosis often present with no symptoms. As sclerosis progresses, signs may include:

• Fatigue
• Mild abdominal discomfort
• Unexplained weight loss
• Jaundice (yellowing of skin or eyes)
• Swelling in the legs or abdomen (edema/ascites)
• Easy bruising or bleeding

Diagnosis

Diagnosis involves a combination of clinical evaluation and testing. Blood tests assess liver function, while imaging studies (e.g., ultrasound, MRI) or liver biopsy may be used to evaluate tissue scarring. The absence of cirrhosis is a key diagnostic consideration for this code.

Treatment Options

Treatment focuses on addressing underlying causes and managing symptoms. This may include lifestyle modifications (e.g., alcohol cessation, weight management), medications to reduce liver inflammation, and monitoring for progression. In severe cases, liver transplantation may be considered.

Prognosis and Follow-Up

The prognosis depends on the extent of scarring and underlying cause. Early intervention can slow progression, but advanced sclerosis may lead to irreversible damage. Regular follow-up with liver function tests and imaging is essential to monitor disease activity.

Complications

• Progressive liver dysfunction
• Increased risk of liver cancer
• Portal hypertension (elevated blood pressure in liver vessels)
• Ascites (fluid buildup in the abdomen)
• Hepatic encephalopathy (brain function changes due to liver failure)

Lifestyle & Prevention

• Limit alcohol intake or avoid it entirely
• Maintain a healthy weight and manage metabolic conditions
• Vaccinate against hepatitis A and B
• Avoid exposure to liver toxins (e.g., certain chemicals, medications)
• Follow a balanced diet to support liver health

When to Seek Professional Help

Seek medical attention if you experience persistent fatigue, jaundice, unexplained weight loss, or abdominal swelling. Early evaluation is critical to prevent progression to more severe liver disease.

Tips for Medical Coders

When coding for hepatic sclerosis (K74.1), ensure documentation supports the absence of cirrhosis. Verify that the clinical notes align with the condition’s definition, as this code is distinct from cirrhosis-related codes. Confirm that underlying causes (if known) are documented separately if applicable.